SELLAS Life Sciences Group Ownership | Who Owns SELLAS Life Sciences Group?


OverviewFinancialsChart

SELLAS Life Sciences Group Ownership Summary


SELLAS Life Sciences Group is owned by 9.95% institutional investors, 0.17% insiders, and 89.89% retail investors. Vanguard group is the largest institutional shareholder, holding 3.36% of SLS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.15% of its assets in SELLAS Life Sciences Group shares.

SLS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSELLAS Life Sciences Group9.95%0.17%89.89%
SectorHealthcare Stocks 57.38%9.40%33.23%
IndustryBiotech Stocks 68.97%8.91%22.12%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group2.29M3.36%$2.38M
Alyeska investment group1.48M3.30%$1.76M
Anson funds management lp1.19M1.75%$1.24M
Geode capital management733.55K1.07%$763.17K
Blackrock430.37K0.96%$512.14K
Brooklyn fi594.92K0.87%$677.15K
Blackrock funding, inc. /de444.21K0.65%$461.98K
Opus capital group238.50K0.35%$248.00K
State street227.73K0.33%$236.84K
Northern trust100.84K0.23%$120.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Anson funds management lp1.19M0.13%$1.24M
Opus capital group238.50K0.03%$248.00K
Alyeska investment group1.48M0.01%$1.76M
Prosperity financial group11.50K0.01%$11.96K
Xtx topco53.43K0.00%$55.56K
Brooklyn fi594.92K0.00%$677.15K
Virtu financial41.16K0.00%$43.00K
Nemes rush group10.00K0.00%$10.40K
Geode capital management733.55K0.00%$763.17K
Mariner50.61K0.00%$52.63K

Top Buyers

HolderShares% AssetsChange
Brooklyn fi594.92K0.00%594.92K
Alyeska investment group1.48M0.01%479.07K
Anson funds management lp1.19M0.13%398.43K
Blackrock430.37K-152.15K
Geode capital management733.55K0.00%128.35K

Top Sellers

HolderShares% AssetsChange
Diametric capital, lp---160.19K
Renaissance---92.94K
Prelude capital management---58.34K
Millennium management---46.34K
Virtu financial41.16K0.00%-38.09K

New Positions

HolderShares% AssetsChangeValue
Brooklyn fi594.92K0.00%594.92K$677.15K
Ubs group127.82K-127.82K$132.93K
Goldman sachs group15.68K-15.68K$16.31K
Belvedere trading12.70K-12.70K$15.11K
Prosperity financial group11.50K0.01%11.50K$11.96K

Sold Out

HolderChange
Qube research-2.00
Allworth financial lp-150.00
Wells fargo & company/mn-301.00
Jpmorgan chase-5.79K
Calton & associates-14.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202435-6,790,16026.08%915.98%18-10.00%5-
Sep 30, 202435-5,385,57032.75%79.63%20-16.67%5150.00%
Jun 30, 2024356.06%4,057,046-47.43%91.57%2460.00%2-66.67%
Mar 31, 202433-7,717,107121.72%2415.94%15-25.00%620.00%
Dec 31, 20233313.79%3,480,63027.06%1213.15%2042.86%5-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.69M2.15%-
Vanguard Institutional Extnd Mkt Idx Tr501.97K0.64%-
Fidelity Extended Market Index393.52K0.50%84.12K
iShares Micro-Cap ETF142.92K0.18%-
BlackRock Extended Equity Market K100.56K0.16%-43.00
Fidelity Total Market Index119.19K0.15%-
Extended Equity Market Fund K99.20K0.14%-1.37K
NT Ext Equity Mkt Idx Fd - L94.41K0.13%33.89K
Northern Trust Extended Eq Market Idx94.41K0.12%33.89K
Fidelity Series Total Market Index83.67K0.11%-2.22K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 05, 2022Stergiou Angelos M. President and CEOSell$16.94K
Dec 05, 2022Burns John Thomas Senior VP, Finance & CAOSell$3.00K
Dec 05, 2022WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec.Sell$5.58K
Dec 02, 2021Stergiou Angelos M. President and CEOSell$13.25K
Dec 02, 2021WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec.Sell$5.30K

Insider Transactions Trends


DateBuySell
2024 Q4--
2023 Q4--
2023 Q1--
2022 Q4-3
2022 Q3--

SLS Ownership FAQ


Who Owns SELLAS Life Sciences Group?

SELLAS Life Sciences Group shareholders are primarily institutional investors at 9.95%, followed by 0.17% insiders and 89.88% retail investors. The average institutional ownership in SELLAS Life Sciences Group's industry, Biotech Stocks , is 68.97%, which SELLAS Life Sciences Group falls below.

Who owns the most shares of SELLAS Life Sciences Group?

SELLAS Life Sciences Group’s largest shareholders are Vanguard group (2.29M shares, 3.36%), Alyeska investment group (1.48M shares, 3.30%), and Anson funds management lp (1.19M shares, 1.75%). Together, they hold 8.41% of SELLAS Life Sciences Group’s total shares outstanding.

Does Blackrock own SELLAS Life Sciences Group?

Yes, BlackRock owns 0.96% of SELLAS Life Sciences Group, totaling 430.37K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 512.14K$. In the last quarter, BlackRock increased its holdings by 152.15K shares, a 54.69% change.

Who is SELLAS Life Sciences Group’s biggest shareholder by percentage of total assets invested?

Anson funds management lp is SELLAS Life Sciences Group’s biggest shareholder by percentage of total assets invested, with 0.13% of its assets in 1.19M SELLAS Life Sciences Group shares, valued at 1.24M$.

Who is the top mutual fund holder of SELLAS Life Sciences Group shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of SELLAS Life Sciences Group shares, with 2.15% of its total shares outstanding invested in 1.69M SELLAS Life Sciences Group shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools